First third-generation CAR T cell application targeting CD19 for the treatment of systemic IgM AL amyloidosis with underlying marginal zone lymphoma

Light chain amyloidosis (AL) is a rare disease caused by the generalized deposition of misfolded free light chains. Patients with immunoglobulin M gammopathy (IgM) and indolent B-cell lymphoma such as marginal zone lymphoma (MZL) may in some instances develop AL amyloidosis. So far, CAR T cells for...

Descripción completa

Detalles Bibliográficos
Autores principales: Korell, Felix, Schönland, Stefan, Schmitt, Anita, Jansen, Madelaine, Farid, Kiavasch, Müller-Tidow, Carsten, Dreger, Peter, Schmitt, Michael, Hegenbart, Ute
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576295/
https://www.ncbi.nlm.nih.gov/pubmed/37838756
http://dx.doi.org/10.1186/s40364-023-00532-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576295/
https://www.ncbi.nlm.nih.gov/pubmed/37838756
http://dx.doi.org/10.1186/s40364-023-00532-2

Ejemplares similares